5610224 THE USE OF LUSPATERCEPT IN PATIENTS WITH β -THALASSAEMIA AND MULTIPLE SYSTEMIC COMPLICATIONS INCREASES HEMOGLOBIN LEVEL, DECREASES TRANSFUSION BURDEN, AND IS UNAFFECTED BY COMPLICATIONS. SINGLE THALASSEMIA AND SICKLE CELL DEPARTEMENT’S EXPERIENCE.

• K.M. Manganas,
• K.A. Kotsiafti,
• X.A. Xydaki,
• D.P. Patsourakos,
• K.A. Aggeli,
• S.C. Savvidis,
• K.I. Koskinas,
• S.D. Delicou

Affiliations

K.M. Manganas

K.A. Kotsiafti

X.A. Xydaki

D.P. Patsourakos

K.A. Aggeli

S.C. Savvidis

K.I. Koskinas

S.D. Delicou